Myelodysplasia

The Myelodysplasia Program of the OHSU Center for Hematologic Malignancies is organized to perform a comprehensive analysis of the state of your disease as well as providing you with insightful information about long-term expectations. Myelodysplasia is a complex set of disorders, which are undergoing detailed and rigorous scientific investigation. Myelodysplasias can be indolent or can have a very aggressive behavior, with evolution to acute leukemia. This complex disorder is relatively frequent in the population but there are only limited therapies available and it still remains that the only curative therapy is receiving a blood or marrow stem cell transplant from another individual, either from a family member or from someone else within the world.

During your visit, you will have the opportunity to learn about your disease, as well as the newest and most promising treatments. We have multiple clinical trials investigating new agents, including drugs which can either decrease your need for blood or platelet transfusion or slow the evolution of your disease. Our team of scientists are actively involved in pursuing the molecular definition of myelodysplasia with the hope that new treatments will be developed by research performed at the Oregon Cancer Institute.

In providing you the comprehensive consultation required, we work closely with our collaborators here within the Division of Hematopathology, six individuals whose entire professional focus is in evaluating bone marrow disorders. In addition, we have the support of a leading national laboratory in cytogenetics, which can also provide further insights into your disease.

In summary, at the Center for Hematologic Malignancies Myelodysplasia Clinic, we will work closely with you to provide you the understanding of your disease and to work into the future for its control and in your improvement in life.

Treating Physicians:
Gabrielle Meyers, M.D.

Make an Appointment

Clinical Trials Related to this Disease